Articles

Linda Bosserman, MD, FACP, talks about the value-based concerns of physicians in the US, including outcomes, survival, toxicity, and cost to patient.

According to Dr. Stainthorpe, the cost of care can be alleviated for patients and providers using imaginative reimbursement approaches such as risk shares and managed entry schemes that pay by outcomes.

Dr. Stainthorpe sheds light on the value-based concerns of oncologists in Europe, which include patient benefit, low side effects, and treatment options.

Andrew Stainthorpe, PhD, PASLU, NICE, talks about why the FDA should not take drug cost into account when weighing the approval of expensive medications.

According to Dr. Mullins, patients are having new conversations with their physicians about the cost of care and their ability to pay for treatment. He points out that some patients are not taking their medications because they cannot afford them, and says that social services need to be established to help these individuals.

Dr. Mullins emphasizes that the role of oncologists is changing, and they should recognize that treatment cost is an important consideration for patients. Having cost information available for patients is one way oncologists can help patients make decisions about their care.

C. Daniel Mullins, PhD, talks about the importance of considering the value equation when it comes to treating oncology patients. Oncologists should have conversations with their patients about clinical effectiveness and affordability in order to determine the best course of treatment. This approach is more challenging, but leads to more patient-centered care.

Dr. Bosserman explains that in her practice, patients want to be involved in their care. They want the truth about their disease, treatment, outcomes, and cost, and they want to hear it from their doctor.

Oncologists should be guided by the research that is being done around outcomes, benefit, and society impact when making value-based care decisions, says Dr. Stainthorpe.

Dr. Stainthorpe shares his belief that when it comes to care decisions, oncology patients should be provided with information about the benefits/outcomes/consequences and cost of their care.